Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)
Clinical trial NCT01475370 · COMPLETED
Trial details
- NCT number
- NCT01475370
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-24
- Primary completion
- 2016-12-22
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.